Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
Launched by SCIENTIFIC INSTITUTE SAN RAFFAELE · Dec 11, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different surgical methods used to remove part of the lung in patients with early-stage lung cancer, specifically a type called non-small cell lung cancer. The researchers are comparing robotic surgery to two other techniques: video-assisted thoracoscopic surgery (VATS) and traditional open surgery. The goal is to understand any complications that might happen during or after these procedures.
To participate in this trial, you must be at least 18 years old and have had surgery for early-stage non-small cell lung cancer since January 2010. The study is currently looking for participants, and anyone who meets these criteria might be eligible to join. If you do participate, you can expect to share your surgical experience, and the researchers will analyze the outcomes to help improve care for future patients. This study is important because it may help doctors determine the safest and most effective surgical options for people with early-stage lung cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pre or post-operative diagnosis of NSCLC surgically treated with pulmonary segmentectomy from 1st January 2010 to the 31st to December 2023.
- • Age \> then 18 years at the moment of surgery
- Exclusion Criteria:
- • Age \< then 18 years at the moment of surgery
- • diagnosis other than NSCLC
About Scientific Institute San Raffaele
The Scientific Institute San Raffaele is a leading research and clinical care institution based in Milan, Italy, dedicated to advancing healthcare through innovative scientific research and high-quality patient care. With a strong emphasis on translational medicine, the institute integrates cutting-edge research with clinical applications, fostering collaboration among scientists, clinicians, and industry partners. San Raffaele is committed to enhancing the understanding of complex diseases and developing novel therapeutic strategies, thereby contributing to the improvement of global health outcomes. Its state-of-the-art facilities and multidisciplinary approach position the institute as a key player in the landscape of clinical trials and biomedical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Rozzano, Milan, Italy
Milan, , Italy
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported